Efficacy and Safety Study of DEB025/Alisporivir Combined to Peg-IFN and Ribavirin in Chronic Hepatitis C Genotype 1 Treatment-naïve Patients
| Status: | Completed |
|---|---|
| Conditions: | Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/21/2016 |
| Start Date: | March 2011 |
| End Date: | August 2013 |
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of DEB025/Alisporivir in Combination With Peg-IFN and Ribavirin in Hepatitis C Genotype 1 Treatment-naïve
This study will assess the safety and efficacy of Alisporivir when added to pegIFN and
Ribavirin to optimize treatment in patient infected with the Hepatitis C virus who have not
been previously treated for this condition
Ribavirin to optimize treatment in patient infected with the Hepatitis C virus who have not
been previously treated for this condition
Inclusion criteria:
- Chronic hepatitis C viral
- HCV genotype
- No previous treatment for hepatitis C infection
- Serum HCV RNA level ≥ 1000 IU/ml assessed by quantitative polymerase chain reaction
or equivalent at screening, no upper limit
- Liver evaluation prior to Baseline: liver biopsy within 3 years or Fibroscan within 6
months
Exclusion criteria:
- HCV genotype different from genotype 1 or co-infection with other HCV genotype
- Co-infection with Hepatitis B or HIV
- Any other cause of relevant liver disease other than HCV
- Presence or history of hepatic decompensation
- ALT ≥ 10 times ULN, more than 1 episode of elevated bilirubin (>ULN) in past 6 months
- Other protocol-defined inclusion/exclusion criteria may apply
We found this trial at
27
sites
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials